BioCentury
ARTICLE | Financial News

Eidos proposes $115M NASDAQ IPO

June 1, 2018 7:16 PM UTC

Eidos Therapeutics Inc. (Palo Alto, Calif.) proposed on May 25 to raise $115 million in an IPO underwritten by J.P. Morgan, BofA Merrill Lynch and Barclays.

In April, the company raised $64 million in a series B round led by RA Capital (see BioCentury, April 6)...

BCIQ Company Profiles

Eidos Therapeutics Inc.